CTNI-53. SINGLE ARM, OPEN-LABEL, MULTICENTER PHASE II STUDY OF THE RADIONUCLIDE 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA
Sylvia C. Kurz(Center for Neuro-Oncology), Erik P. Sulman(NYU Langone Health), Elçin Zan(Cornell University), Zacharia Sawaged(NYU Langone Health), David Zagzag(NYU Langone Health), Douglas Kondziolka(Neurological Surgery), John G. Golfinos(NYU Langone Health), Jasone Gurewitz(NYU Langone Health), Hector Sevillano-Torres(NYU Langone Health), Matija Snuderl, Christine Cordova(Cleveland Clinic), Joshua S. Silverman(NYU Langone Health), Andrea B. Troxel(Andover Eye Associates)
Cited by 1
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k